{
  "actions": [
    {
      "acted_at": "2022-03-18",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2022-03-18",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Ways and Means.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr7166-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "T000483",
      "district": "6",
      "name": "Trone, David J.",
      "original_cosponsor": false,
      "sponsored_at": "2022-05-19",
      "state": "MD",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-03-18",
  "number": "7166",
  "official_title": "To amend the Internal Revenue Code of 1986 to provide for extended expensing of pharmaceutical manufacturing property, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Make Medicine in America Again Act",
  "sponsor": {
    "bioguide_id": "M001195",
    "district": "2",
    "name": "Mooney, Alexander X.",
    "state": "WV",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-03-18",
  "subjects": [
    "Taxation"
  ],
  "subjects_top_term": "Taxation",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2022-03-18",
    "date": "2022-03-23T14:52:39Z",
    "text": "Make Medicine in America Again Act\n\nThis bill provides tax incentives for the manufacture of pharmaceutical property, equipment, buildings, or facilities in the United States. Specifically it allows bonus depreciation for such property and a business-related tax credit for 50% of expenditures for (1) wages for services performed in a U.S. pharmaceutical manufacturing business, (2) the tangible personal property of such a business, and (3) any direct or indirect costs paid or incurred in a U.S. pharmaceutical manufacturing business."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Make Medicine in America Again Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Make Medicine in America Again Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Internal Revenue Code of 1986 to provide for extended expensing of pharmaceutical manufacturing property, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2022-12-29T22:03:48Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr7166.xml"
}